1Sugimura K, Taylor KD, Lin YC, et al. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet, 2003, 72:509-518.
2Judge T, Lichtenstein GR. The NOD2 gene and Crohn's disease:another triumph for molecular genetics. Gastroenterology, 2002,122 : 826-828.
3Sendid B, Quinton JF, Charrier G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol, 1998, 93:1306-1310.
4Subhani J, Montgomery SM, Ounder RE, et al. Concordance rates of twins and siblings in inflammatory bowel disease. Gut, 1998,42 : 40-42.
5Bonen DK, Cho JH. The genetics of inflammatory bowel disease.Gastroenterology, 2003, 124: 521-536.
6Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology, 2002, 122: 867-874.
7Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology, 2003, 124:993-1000.
8Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology, 2003,124: 140-146.
9Hugot JP, Chamaillard M, gouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn' s disease.Nature, 2001, 411 : 599-603.
10Rosenstiel P, Fantini M, Brautigam K, et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology, 2003, 124:1001-1009.
3Dianne S, Robert T. Coping methods of patients with inflammatory bowel disease and prediction of perceived health, functional status, and well-being[ J ]. Gastroenterol Nuts, 1998,21 ( 3 ) : 112-118.
4Sands BE. From symptom to diagnosis : clinical distinctions among various forms of intestinal inflammation [ J ]. Gastroenterology, 2004,126 (6) :1518-1532.
5Grenth J, Torok HP, Koenig A, et al. Comparison of inflammatory bowel disease at younger and older age [ J ]. Eur J Med Res, 2004,9 (12) : 552-554.
6Casellas F,Aleala MJ,Prieto L, et al. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire [ J ]. Am J Gastroenterol, 2004, 99(3) :457-461.
7Hjortswang H, Jarnerot G, Curman B, et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis[ J ]. Eur J Gastroenterol Hepatol,2003, 15(9) :1011-1020.
8Mittermaier C, Dejaco C, Waldhoer T, et al. Impact depressive mood on relapse in patients with inflammatory bowel disease:a prospective 18- month follow-up study[ J]. Psychosomatic Medicine ,2004,66( 1 ) :79- 84.
9SANDS BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation [ J ]. Gastroenterology,2004,126 (6) : 1518 - 1532.
10JOACHIM G. An assessment of social support in people with inflammatory bowel disease[ J]. Gastroenterol Nurs ,2002,25 (6) : 246 - 251.
